Poly Medicure Limited - Neraca (Quarterly)

Poly Medicure Limited
IN ˙ NSEI
₹ 2,037.55 ↓ -1.50 (-0.07%)
2025-09-05
BAHAGING PRESYO
Talaan ng Balanse (Quarterly)

Neraca Poly Medicure Limited menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2020
09-30
2021
03-31
2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
Cash 283 50 430 78 811 71 1,461 121 1,921 87
Change (%) -82.50 767.58 -81.95 944.87 -91.29 1,968.86 -91.75 1,493.90 -95.47
Assets Current 3,432 7,041 8,220 7,834 7,835 8,067 8,124 8,416 19,240 19,170
Change (%) 105.13 16.75 -4.69 0.01 2.96 0.70 3.60 128.62 -0.37
Assets 8,083 12,237 13,358 13,768 14,483 15,772 16,972 18,587 30,523 31,925
Change (%) 51.39 9.16 3.07 5.19 8.90 7.61 9.52 64.22 4.59
Liabilities 3,118 2,582 3,180 2,894 3,138 3,356 3,591 3,886 4,610 4,268
Change (%) -17.21 23.18 -9.01 8.46 6.93 7.02 8.21 18.63 -7.42
Equity 4,965 9,656 10,178 10,875 11,345 12,416 13,380 14,701 25,913 27,657
Change (%) 94.48 5.41 6.85 4.32 9.45 7.76 9.87 76.27 6.73
Liabilities And Stock Equity 8,083 12,237 13,358 13,768 14,483 15,772 16,972 18,587 30,523 31,925
Change (%) 51.39 9.16 3.07 5.19 8.90 7.61 9.52 64.22 4.59

Source: Capital IQ

Other Listings
IN:531768
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista